Onco-Innovations Limited (ONCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in thousands)
| 04-2025 | 04-2024 | 04-2023 | |
| Sales | 65 | 0 | 0 |
| Operating Expenses | 4,761 | 266 | 0 |
| Operating Income | -4,696 | -266 | 0 |
| Other Income | -3,799 | -155 | 0 |
| Pre-tax Income | -8,495 | -421 | 0 |
| Net Income Continuous | -8,495 | -421 | 0 |
| Net Income | $-8,495 | $-421 | $0 |
| EPS Basic Total Ops | -0.24 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.24 | -0.01 | N/A |
| EPS Diluted Total Ops | -0.24 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.24 | -0.01 | N/A |
| EBITDA(a) | $-4,696 | $-266 | $0 |